RSS Feeds
Risks for Bleeding in Patients with Pulmonary Embolism Treated with Thrombolytic Agents
- University of California, San Diego, Medical Center, San Diego, CA 92103-8372. Department of Veterans Affairs Medical Center, New Orleans, LA 70146. Merrithew Memorial Hospital, Martinez, CA 94553. Union Hospital, Lynn, MA 01904. Henry Ford Heart and Vascular Institute, Detroit, MI 48202-2691.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
We appreciate the thoughtful letters about our article [1]. Although a difference of opinion appears to exist, our article may have been misinterpreted. We did not imply that we favor a broader use of thrombolytic drugs for patients with acute pulmonary embolism. Our purpose was to …
This 100-word excerpt has been provided in the absence of an abstract.
